Title : Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial.

Pub. Date : 2017 May 1

PMID : 28291866






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Importance: In the Improved Reduction of Outcomes: Vytorin Efficacy International Trial, intensive low-density lipoprotein cholesterol (LDL-C)-reducing therapy with ezetimibe/simvastatin compared with simvastatin alone was associated with a significant reduction in cardiovascular events in 18 144 patients after acute coronary syndrome. density lipoprotein cholesterol component of oligomeric golgi complex 2 Homo sapiens